Albertini MR, Zuleger CL, Ranheim EA, Shiyanbola O, et al. Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma. Melanoma Res 2024 May 20. doi: 10.1097/CMR.0000000000000975.
PMID: 38768442